Global Retirement Partners’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-44
| Closed | -$1.11K | – | 3509 |
|
|
2024
Q2 | $1.11K | Hold |
44
| – | – | ﹤0.01% | 3131 |
|
|
2024
Q1 | $1.28K | Sell |
44
-200
| -82% | -$5.83K | ﹤0.01% | 2901 |
|
|
2023
Q4 | $6.01K | Hold |
244
| – | – | ﹤0.01% | 2250 |
|
|
2023
Q3 | $4.57K | Sell |
244
-6
| -2% | -$112 | ﹤0.01% | 2224 |
|
|
2023
Q2 | $5.99K | Buy |
250
+17
| +7% | +$407 | ﹤0.01% | 2132 |
|
|
2023
Q1 | $5.6K | Sell |
233
-155
| -40% | -$3.73K | ﹤0.01% | 2122 |
|
|
2022
Q4 | $9.7K | Hold |
388
| – | – | ﹤0.01% | 1793 |
|
|
2022
Q3 | $10K | Sell |
388
-20
| -5% | -$515 | ﹤0.01% | 1673 |
|
|
2022
Q2 | $9K | Hold |
408
| – | – | ﹤0.01% | 1667 |
|
|
2022
Q1 | $8K | Buy |
+408
| New | +$8K | ﹤0.01% | 1690 |
|
|
2021
Q4 | – | Sell |
-408
| Closed | -$19K | – | 375 |
|
|
2021
Q3 | $19K | Hold |
408
| – | – | ﹤0.01% | 1211 |
|
|
2021
Q2 | $20K | Hold |
408
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q1 | $21K | Sell |
408
-6
| -1% | -$309 | ﹤0.01% | 1085 |
|
|
2020
Q4 | $21K | Buy |
414
+5
| +1% | +$254 | ﹤0.01% | 1009 |
|
|
2020
Q3 | $16K | Buy |
409
+122
| +43% | +$4.77K | ﹤0.01% | 989 |
|
|
2020
Q2 | $12K | Buy |
+287
| New | +$12K | ﹤0.01% | 1057 |
|
|
2019
Q2 | – | Sell |
-180
| Closed | -$5K | – | 1598 |
|
|
2019
Q1 | $5K | Hold |
180
| – | – | ﹤0.01% | 1225 |
|
|
2018
Q4 | $4K | Hold |
180
| – | – | ﹤0.01% | 1192 |
|
|
2018
Q3 | $6K | Sell |
180
-170
| -49% | -$5.67K | ﹤0.01% | 1163 |
|
|
2018
Q2 | $11K | Hold |
350
| – | – | ﹤0.01% | 968 |
|
|
2018
Q1 | $11K | Buy |
+350
| New | +$11K | ﹤0.01% | 934 |
|